Early use of everolimus improved renal function after adult deceased donor liver transplantation

Early use of everolimus improved renal function after adult deceased donor liver transplantation

Background : Tacrolimus (TAC) is a main therapy for liver transplantation (LT) patients, but it has side effects such as chronic nephrotoxicity that progressively aggravate renal function. The purpose of this study was to retrospectively compare the renal function between a TAC group and a combinati...

Full description

Bibliographic Details
Main Authors:	Seohee Lee, Jong Man Kim, Sangjin Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
Format:	Article
Language:	English
Published:	Korean Society for Transplantation 2021-03-01
Series:	Korean Journal of Transplantation
Subjects:	renal insufficiency; immunosuppression; calcineurin inhibitors
Online Access:	http://journaleditor.inforang.com/journal/view.html?doi=10.4285/kjt.20.0043

Similar Items

FIRST EXPERIENCE IN SYSTEMIC ADMINISTRATION OF EVEROLIMUS IN RENAL TRANSPLANTATION FROM EXPANDED CRITERIA DONORS IN RUSSIAN FEDERATION
by: I. V. Uliyankina, et al.
Published: (2017-01-01)

Early reoperation after adult living-donor liver transplantation is associated with poor survival
by: Manuel Lim, et al.
Published: (2019-12-01)

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
by: Jong Man Kim, et al.
Published: (2016-09-01)

Impact of Graft Weight Change During Perfusion on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation
by: Jong Man Kim, et al.
Published: (2021-02-01)

EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
by: E. I. Prokopenko
Published: (2010-06-01)

THE USE OF EVEROLIMUS IN KIDNEY TRANSPLANTATION FROM EXPANDED CRITERIA DONORS
by: I. V. Ulyankina, et al.
Published: (2009-06-01)

Changes in glomerular filtration rate in liver recipients after reduced exposure to calcineurin inhibitors with concomitant everolimus administration within the first year after immunosuppression conversion
by: V. E. Syutkin, et al.
Published: (2022-01-01)

The Occurrence of Primary Hepatic Adenoma in Deceased Donor Renal Transplant Recipient
by: Yu-Tso Liao, et al.
Published: (2014-01-01)

Conversion to everolimus to preserve kidney function in a heart transplant recipient, a personalized approach of immunos uppressive therapy
by: N. N. Koloskova, et al.
Published: (2018-09-01)

Comparison of clinical outcomes of deceased donor kidney transplantations, with a focus on three induction therapies
by: Eun Sung Jeong, et al.
Published: (2019-12-01)

Generic Tacrolimus (Tacrobell®) Shows Comparable Outcomes to Brand-Name Tacrolimus in the Long-Term Period After Adult Deceased Donor Liver Transplantation
by: Kim JM, et al.
Published: (2019-12-01)

The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
by: Emel Isiktas Sayilar, et al.
Published: (2022-11-01)

Immunosuppression with prolonged-release tacrolimus in kidney or liver transplantation in India
by: Dinesh Khullar, et al.
Published: (2017-01-01)

Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients
by: Amelia R. Cossart, et al.
Published: (2021-04-01)

Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients
by: Sepideh Zununi Vahed, et al.
Published: (2015-02-01)

Author Correction: The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
by: Sang Jin Kim, et al.
Published: (2022-12-01)

Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
by: Niklas Bergh, et al.
Published: (2020-04-01)

Use of everolimus as an alternative to calcineurin inhibitors in renal allograft recipients: A single South Indian center's experience
by: Manns Manohar John, et al.
Published: (2019-01-01)

Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study
by: Mohamed Hashim, et al.
Published: (2020-09-01)

The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
by: Sang Jin Kim, et al.
Published: (2022-11-01)

PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION
by: M. V. Avxentyeva, et al.
Published: (2015-06-01)

Calcineurin inhibitors: status quo and perspectives
by: Erdmann Frank, et al.
Published: (2011-04-01)

Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
by: Incheon Kang, et al.
Published: (2021-10-01)

Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients
by: Charat Thongprayoon, et al.
Published: (2020-07-01)

Disseminated Mycobacterium bovis infection after deceased donor liver transplantation: A case report
by: Kayvon Sotoudeh, et al.
Published: (2021-08-01)

First case report of domino living donor liver transplantation in Korea
by: Jong Man Kim, et al.
Published: (2019-06-01)

Differences in Medication Adherence between Living and Deceased Donor Kidney Transplant Patients
by: K Denhaerynck, et al.
Published: (2014-01-01)

Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation
by: Elena Crespo, et al.
Published: (2022-06-01)

Neurological Complications after Deceased Donor Liver Transplant: A Case Series from a Public Sector Hospital
by: Kanimozhi Rathinasamy, et al.
Published: (2023-04-01)

The peripheral NK cell repertoire after kidney transplantation is modulated by different immunosuppressive drugs
by: Christine eNeudoerfl, et al.
Published: (2013-02-01)

Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation
by: Jongwook Oh, et al.
Published: (2020-01-01)

Elderly Hepatocellular Carcinoma Patients: Open or Laparoscopic Approach?
by: Jong Man Kim, et al.
Published: (2020-08-01)

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients
by: Antony Brayan Campos-Salazar, et al.
Published: (2018-11-01)

First and second kidney transplantations from living donors offer comparable outcomes for patients
by: Namkee Oh, et al.
Published: (2022-09-01)

Foremost Concepts in Mechanisms of De Novo Post-Liver Transplantation Malignancy
by: Milena Peruhova, et al.
Published: (2021-06-01)

Belatacept in Kidney Transplantation: What Are the True Benefits? A Systematic Review
by: Yannis Lombardi, et al.
Published: (2022-07-01)

A Retrospective Review of Calcineurin Inhibitors’ Impact on Cytomegalovirus Infections in Lung Transplant Recipients
by: Rita Nogueiras-Álvarez, et al.
Published: (2021-11-01)

Analysis of early use of everolimus with low-dose calcineurin inhibitors in kidney transplant recipient
by: I. G. Kim, et al.
Published: (2019-10-01)

Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment
by: Jong Hoon Lee, et al.
Published: (2013-12-01)

Pancreas transplantation: review
by: Roberto Ferreira Meirelles Júnior, et al.